journal article·2024-07Open access

Assembled Embedded 3D Hydrogel System for Asynchronous Drug Delivery to Inhibit Postoperative Recurrence of Malignant Glioma and Promote Neurological Recovery

Yang Hu, Liming Zhou, Zhenning Wang, Zhiming Ye, Huiling Liu, Yi Lu, Zhihui Qi, Kunhua Yang, Jianhao Zeng, Huimin Li, Ruizhe Tang, Jiaoyan Ren, Rui Guo, Maojin Yao

Advanced Functional Materials· Volume 34· Issue 30

Abstract

Abstract Surgical resection of glioblastoma multiforme (GBM) often results in tumor recurrence and mild neurologic deficits. Here, a 3D asynchronous drug delivery system is innovatively developed to address the dual challenges of GBM recurrence and postoperative neurological deficit. Based on transcriptome analysis of tumor cells and tumor microenvironment (TME) cells between primary and recurrent mouse GBM tissues, a novel dual‐targeting approach is developed to combine mTOR pathway inhibition with microglia/macrophage repolarization. Then, in situ injectable methacrylated gelatin (GelMA) is constructed to perfectly fit into the tumor resection cavity and achieve direct delivery of dual‐targeted drugs, exhibiting outstanding postoperative GBM inhibitory effects in vivo. At the same time, neurotrophic factor‐saturated 3D‐printed GelMA patches are used to construct a 3D asynchronous drug delivery system, allowing gradual penetration of the neurotrophic factors into the underlying hydrogel to promote axonal sprouting after GBM suppression. Notably, this 3D asynchronous drug delivery system promotes neurological recovery without weakening the efficacy of inhibiting tumor recurrence. Therefore, this study not only proposes a new dual‐targeted GBM treatment strategy but also pioneers the construction of a 3D asynchronous drug delivery system for the comprehensive treatment of GBM. This study is expected to improve the poor prognosis of patients with GBM.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Glioma Diagnosis and Treatment · 3D Printing in Biomedical Research · Neurogenesis and neuroplasticity mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Respiratory Disease National Clinical Research Center for Respiratory Disease National Center for Respiratory Medicine Department of Thoracic Surgery and Oncology Guangzhou Institute of Respiratory Health The First Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong 510182 P. R. China

Key Laboratory of Biomaterials of Guangdong Higher Education Institutes Key Laboratory of Regenerative Medicine of Ministry of Education Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development Department of Biomedical Engineering Jinan University Guangzhou 510632 P. R. China

Department of Neurosurgery The Tenth Affiliated Hospital Southern Medical University (Dongguan People's Hospital) Dongguan 523018 P. R. China

Department of Anesthesia The First Affiliated Hospital of Sun Yat‐sen University Guangzhou Guangdong 510080 P. R. China

Department of Microbiology Immunology, and Cancer Biology University of Virginia Health System Charlottesville VA 22908 USA

School of Food Sciences and Engineering South China University of Technology Guangzhou 510641 P. R. China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China

References (55)

Show source-provided references
1. 10.1188/16.CJON.S1.2-810.1188/16.CJON.S1.2-8 ↗
2. 10.1158/0008-5472.CAN-21-353410.1158/0008-5472.CAN-21-3534 ↗
3. 10.3171/foc.2006.20.4.210.3171/foc.2006.20.4.2 ↗
4. 10.1016/j.jconrel.2018.05.00810.1016/j.jconrel.2018.05.008 ↗
5. 10.1038/nrc207310.1038/nrc2073 ↗
6. 10.1007/s11060-012-0807-610.1007/s11060-012-0807-6 ↗
7. Lawrie T. A. · Cochrane Database Syst. Rev. · 2019 · 8
8. 10.1016/S0169-409X(02)00054-610.1016/S0169-409X(02)00054-6 ↗
9. 10.7150/ijbs.8353110.7150/ijbs.83531 ↗
10. 10.3390/cells1003048410.3390/cells10030484 ↗
11. 10.3390/brainsci1205056710.3390/brainsci12050567 ↗
12. 10.3390/pharmaceutics1303035710.3390/pharmaceutics13030357 ↗
13. 10.1007/s12975-019-00721-y10.1007/s12975-019-00721-y ↗
14. 10.1002/adhm.20180139110.1002/adhm.201801391 ↗
15. 10.1016/j.ijbiomac.2023.12714310.1016/j.ijbiomac.2023.127143 ↗
16. 10.1016/j.jconrel.2014.04.01410.1016/j.jconrel.2014.04.014 ↗
17. 10.3390/polym1504102610.3390/polym15041026 ↗
18. 10.1016/j.mtla.2019.10043810.1016/j.mtla.2019.100438 ↗
19. 10.1146/annurev.neuro.24.1.67710.1146/annurev.neuro.24.1.677 ↗
20. Sun Z. · Mol. Pharmaceutics · 2020 · 17 · 373
21. 10.1002/adfm.20231433010.1002/adfm.202314330 ↗
22. 10.1002/advs.20160041010.1002/advs.201600410 ↗
23. 10.1172/JCI5867510.1172/JCI58675 ↗
24. 10.1016/j.biomaterials.2010.07.08410.1016/j.biomaterials.2010.07.084 ↗
25. 10.1523/JNEUROSCI.2769-09.200910.1523/JNEUROSCI.2769-09.2009 ↗
26. 10.1089/neu.2000.17.121910.1089/neu.2000.17.1219 ↗
27. 10.1016/j.cell.2015.04.01210.1016/j.cell.2015.04.012 ↗
28. 10.1038/nature2401410.1038/nature24014 ↗
29. 10.1038/s41586-019-1563-y10.1038/s41586-019-1563-y ↗
30. 10.1038/s41587-019-0114-210.1038/s41587-019-0114-2 ↗
31. 10.2967/jnumed.121.26331810.2967/jnumed.121.263318 ↗
32. 10.1038/nm.333710.1038/nm.3337 ↗
33. 10.1634/theoncologist.2009-017810.1634/theoncologist.2009-0178 ↗
34. 10.1038/s41467-019-11674-z10.1038/s41467-019-11674-z ↗
35. 10.4103/1673-5374.36017010.4103/1673-5374.360170 ↗
36. 10.1002/jbm.a.3731010.1002/jbm.a.37310 ↗
37. 10.1016/j.biomaterials.2015.08.04510.1016/j.biomaterials.2015.08.045 ↗
38. 10.1016/j.biomaterials.2010.03.06410.1016/j.biomaterials.2010.03.064 ↗
39. 10.1002/adhm.20210147610.1002/adhm.202101476 ↗
40. 10.1007/s13206-018-3101-710.1007/s13206-018-3101-7 ↗
41. 10.1016/j.jmbbm.2020.10397910.1016/j.jmbbm.2020.103979 ↗
42. 10.1016/j.csbj.2018.10.01110.1016/j.csbj.2018.10.011 ↗
43. 10.1016/j.mtbio.2023.10061410.1016/j.mtbio.2023.100614 ↗
44. 10.1002/btm2.1027410.1002/btm2.10274 ↗
45. 10.1016/S0165-5728(01)00304-610.1016/S0165-5728(01)00304-6 ↗
46. 10.1016/S0022-510X(02)00398-210.1016/S0022-510X(02)00398-2 ↗
47. 10.1111/j.1749-6632.2001.tb03823.x10.1111/j.1749-6632.2001.tb03823.x ↗
48. 10.1016/j.carbpol.2021.11894310.1016/j.carbpol.2021.118943 ↗
49. 10.1021/acsami.8b0660710.1021/acsami.8b06607 ↗
50. 10.1016/j.mtcomm.2022.10428510.1016/j.mtcomm.2022.104285 ↗
51. 10.1016/j.jconrel.2012.03.00210.1016/j.jconrel.2012.03.002 ↗
52. 10.1111/j.1365-2990.2006.00729.x10.1111/j.1365-2990.2006.00729.x ↗
53. 10.1093/noajnl/vdab12510.1093/noajnl/vdab125 ↗
54. 10.1126/scitranslmed.aaw784310.1126/scitranslmed.aaw7843 ↗
55. 10.1016/j.celrep.2017.03.03810.1016/j.celrep.2017.03.038 ↗